Bliss evaluation of the results of cell viability of FX-9 combination with azacitidine, DCA, doxorubicin or carboplatin in PC-3, LNCaP and Adcarc1258.
收藏NIAID Data Ecosystem2026-03-12 收录
数据链接：
官方服务：
资源简介：
Bliss evaluation of the results of cell viability of FX-9 combination with azacitidine, DCA, doxorubicin or carboplatin in PC-3, LNCaP and Adcarc1258.
创建时间：
2021-08-25
